Our Pipeline
Tes Pharma is focused on delivering proprietary first-in-class drug candidates for oncology and metabolic diseases.
Target
(Disease) Disease
(Disease) Disease
Discovery
Preclinical
Clinical
FXR
Agonists
Licensed to Intercept Pharmaceuticals
Metabolic
ACMSD
Inhibitors
Metabolic
NR2F6
Antagonists
Cancer
LRH-1
Inverse agonists
Partnered with Sterling
Cancer